Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Frontiers in Medicine|June 18, 2025
Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, CanadaJean-Sébastien Delisle, Diane Fournier, Kim Santerre, et al.British Journal of Cancer|January 4, 2022
Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patternsNouredin Messaoudi, David Henault, David Stephen, et al.Oncoimmunology|September 18, 2023
Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapyDavid Henault, David Stephen, Pierre-Antoine St-Hilaire, et al.Journal for Immunotherapy of Cancer|January 21, 2025
Art of TIL immunotherapy: SITC's perspective on demystifying a complex treatmentSimon Turcotte, Marco Donia, Brian Gastman, et al.Cancers|September 9, 2022
MHC Class II Expression Influences the Composition and Distribution of Immune Cells in the Metastatic Colorectal Cancer MicroenvironmentBrian D Griffith, Simon Turcotte, Jenny Lazarus, et al.The Journal of Clinical Investigation|March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumorsAlena Gros, Paul F Robbins, Xin Yao, et al.Frontiers in Medicine|November 3, 2025
Correction: Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, CanadaJean-Sébastien Delisle, Diane Fournier, Kim Santerre, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver MetastasesVinod P Balachandran, Arshi Arora, Mithat Gönen, et al.Cancer Immunology Research|November 21, 2022
CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic CancerCélia Jacoberger-Foissac, Isabelle Cousineau, Yacine Bareche, et al.Bioorganic & Medicinal Chemistry Letters|August 29, 2012
Phenylalanine derivatives as GPR142 agonists for the treatment of type II diabetesXiaohui Du, Yong-Jae Kim, Sujen Lai, et al.Pageof 7